A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
he implantable cardioverter-defibrillator (ICD) is an established treatment for the prevention of sudden cardiac death in patients with a history of lifethreatening ventricular tachyarrhythmias, 1 and recent studies have reported their efficacy in the primary prevention of sudden cardiac death in patients with structural heart disease and decreased left ventricular (LV) function. 2-4 Therefore, the number of cases of prophylactic use of ICDs has increased worldwide, and as both the number ofdoi:10.1253/circj.70.273 pmid:16501292 fatcat:phchuqugy5c2vow2qqcmsmlea4